Expression of MAGE, gp100 and tyrosinase genes in uveal melanoma cell lines

Melanoma Research

Volumn 8, Issue 1, 1998, Pages 11-16

  Luyten, G P M ^a   Van Der Spek, C W ^b   Brand, I ^a   Sintnicolaas, K ^c   De Waard Siebinga, I ^b   Jager, M J ^b   De Jong, P T V M ^d   Schrier, P I ^b   Luider, T M ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c CENTRAL LABORATORY   (Netherlands)

^d NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

Cell lines; Gp100; MAGE; Tyrosinase; Uveal melanoma

Indexed keywords

GLYCOPROTEIN GP 100; HLA ANTIGEN CLASS 1; MAGE PROTEIN; MELANOMA ANTIGEN; MELANOMA ANTIGEN 1; MELANOMA ANTIGEN 2; MELANOMA ANTIGEN 3; MONOPHENOL MONOOXYGENASE; UNCLASSIFIED DRUG;

ARTICLE; COMPLEMENT ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSTIMULATION; LYMPHOCYTOTOXICITY; MELANOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; UVEA TUMOR;

ANTIGENS, NEOPLASM; CYTOTOXICITY TESTS, IMMUNOLOGIC; DNA PRIMERS; HLA-A ANTIGENS; HUMANS; MELANOMA; MEMBRANE GLYCOPROTEINS; MONOPHENOL MONOOXYGENASE; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; UVEAL NEOPLASMS;

EID: 0031916525     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199802000-00003     Document Type: Article

References (34)

1. Egan KM, Cetane JM, Glynn RJ, et al. Epidemiologie aspects of uveal melanoma. Surv Ophthalmol 1988; 32: 239-251.
2. Kath R, Hayungs J, Bornfeld N, et al. Prognosis and treatment of disseminated uveal melanoma. Cancer 1993; 72: 2219-2223.
3. Dranoff G, Jaffee E, Lazenby A, et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 1993; 90: 3539-3543.
4. Pardoll DM. New strategies for enhancing the immunogenicity of tumors. Curr Opin Immunol 1993: 5: 719-725.
5. Whelchel JC, Farah SE, McLean IW, et al. Immmunohistochemistry of infiltrating lymphocytes in uveal melanoma. Invest Ophthalmol Vis Sci 1993: 34: 2603-2606.
6. Tobal K, Deuble K, McCartney A, et al. Characterization of cellular infiltration in choroidal melanoma. Melanoma Res 1993; 3: 63-65.
7. Huang X-Q, Mitchell MS, Liggett PE, et al. Nonfastidious, melanoma-specific CD8+ cytotoxic lymphocytes from choroidal melanoma patients. Cancer lmmunol lmmunother 1994; 38: 399-405.
8. Germain RN. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 1994; 76: 287-299.
9. Van der Bruggen P, Traversari C, Chomez P, et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991; 254: 1643-1647.
10. Traversari C, Van der Bruggen P, Luescher IF, et al. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-Al by cytotoxic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med 1992; 176: 1453-1457.
11. De Smet C, Lurquin C, Van der Bruggen P, et al. Sequence and expression pattern of the human MAGE2 gene. Immunogenetics 1994; 39: 121-129.
12. Gaugler B, Van den Eynde B, Van der Bruggen P, et al. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med 1994; 179: 921-930.
13. Adema GJ, de Boer AJ, Vogel AM, et al. Molecular characterization of the melanocyte lineage-specific antigen gp100. J Biol Chem 1994; 269: 20126 20133.
14. Bakker ABH, Schreurs MWJ, de Boer AJ, et al. Melanocyte lineage-specific antigen gp100 is recognized by melanoma derived tumor infiltrating lymphocytes. J Exp Med 1994; 179: 1005-1009.
15. Brichard V, Van Pel A, Wolfel T, et al. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1993; 178: 489-495.
16. Mooy CM, De Jong PTVM. Prognostic parameters in uveal melanoma: a review. Surv Ophthalmol 1996; 41: 215-228.
17. Van Der Pol JP, Jager MJ, De Wolff-Rouendaal D, et al. Heterogeneous expression of melanoma-associated antigens in uveal melanoma. Curr Eye Res 1987; 6: 757-765.
18. Luyten GPM, Naus NC, Mooy CM, et al. Establishment and characterization of primary and metastatic uveal melanoma cell lines. Int J Cancer 1996; 66: 1 -8.
19. Ma D, Luyten GPM, Luider TM, et al. Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model. Invest Ophthalmol Vis Sci 1995; 36: 435-441.
20. Luyten GPM, Mooy CM, De Jong PTVM, et al. A chicken embryo model to study the growth of human uveal melanoma. Biochetn Biophys Res Commun 1993; 192: 22-29.
21. Kan-Mitchell J, Mitchell MS, Rao N, et al. Characterization of uveal melanoma cell lines that grow as xenografts in rabbit eyes. Invest Ophthalmol Vis Sci 1989;30:829-834.
22. Ksander BR, Rubsamen PE, Olsen KR, et al. Studies of tumor-infiltrating lymphocytes from a human choroidal melanoma. Invest Ophthalmol Vis Sci 1991; 32: 3198-3208.
23. De Waard-Siebinga I, Blom DJR, Griffioen M, et al. Establishment and characterization of an uveal-melanoma cell line. Int J Cancer 1995; 62: 155 - 161.
24. Auffray C, Rougeon E Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur J Biochem 198; 107: 303.
25. Brossait P, Keilholz U, Scheibenbogen C, et al. Detection of residual tumor cells in patients with malignant melanoma responding to immunotherapy. J Immunother 1994; 15: 38-41.
26. Browning MJ, Krausa P, Rowan A, et al. Tissue typing the HLA-A locus from genomic DNA by sequence-specific PCR: comparison of HLA genotype and surface expression on colorectal tumor cell lines. Proc Natl Acad Sci USA 1993; 90: 2842-2485.
27. Krausa P, Moses JH, Bodmer WF, Bodmer JG, Browning M. HLA-A locus alleles identified by sequence specific PCR. Lancet 1993; 341: 121-122.
28. Mitchell MS, Liggett PE, Green RL, et al. Sustained regression of a primary choroidal melanoma under the influence of a therapeutic melanoma vaccine. J Clin Oncol 1994; 12: 396-401.
29. Mulcahy KA, Rimoldi D, Brasseur F, et al. Infrequent expression of the MAGE gene family in uveal melanomas. Int J Cancer 1996; 66: 738-742.
30. Adema GJ, de Boer AJ, van't Hullenaar R, et al. Melanocyte lineage-specific antigens recognized by monoclonal antibodies NKI-beteb, HMB-50, and HMB-45 are encoded by a single cDNA. Am J Pathol 1993; 143: 1579-1585.
31. Steuhl KP, Rohrbach JM, Knorr M, et al. Significance, specificity, and ultrastructural localization of HMB-45 antigen in pigmented ocular tumors. Ophthalmology 1993; 100: 208-215.
32. Robbins PF, El-Gamil M, Kawakami Y, et al. Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res 1994; 54: 3124-3126.
33. Celis E, Tsai V, Crimi C, et al. Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc Natl Acad Sci USA 1994; 91: 2105-2109.
34. De Waard-Siebinga I, Visseren MJW, Blom DJR, et al. Uveal melanoma cells can be lysed by tyrosinase- and MAGE-specific CTL clones. Invest Ophthalmol Vis Sci 1996; 37: S622.